Ngā hua rapu - Keiji Tsuji
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double‐blind, controlled trial mā Hisashi Hidaka, Shigehiro Kokubu, Takahiro Sato, Shinji Katsushima, Namiki Izumi, Takumi Igura, Shingo Asahara, Kazuo Notsumata, Yukio Osaki, Keiji Tsuji, Hirofumi Kawanaka, Tomohiko Akahoshi, Shozo Hirota, Shoichi Matsutani
I whakaputaina 2017Artigo -
2
Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection mā Xiaoming Cheng, Takuro Uchida, Yuchen Xia, Regina Umarova, Chun‐Jen Liu, Pei‐Jer Chen, Anuj Gaggar, Vithika Suri, Marcus M. Mücke, Johannes Vermehren, Stefan Zeuzem, Yuji Teraoka, Mitsutaka Osawa, Hiroshi Aikata, Keiji Tsuji, Nami Mori, Shuhei Hige, Yoshiyasu Karino, Michio Imamura, Kazuaki Chayama, T. Jake Liang
I whakaputaina 2020Artigo -
3
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma mā Hironori Ochi, Masayuki Kurosaki, Kouji Joko, Toshie Mashiba, Nobuharu Tamaki, Kaoru Tsuchiya, Hiroyuki Marusawa, Toshifumi Tada, Shinichiro Nakamura, Ryoichi Narita, Yasushi Uchida, Takehiro Akahane, Masahiko Kondo, Nami Mori, Shintaro Takaki, Keiji Tsuji, Atsunori Kusakabe, Koichiro Furuta, Haruhiko Kobashi, Hirotaka Arai, Michiko Nonogi, Takashi Tamada, Chitomi Hasebe, Namiki Izumi
I whakaputaina 2022Artigo -
4
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter stud... mā Toshie Mashiba, Kouji Joko, Masayuki Kurosaki, Hironori Ochi, Yukio Osaki, Yuji Kojima, Ryo Nakata, Tohru Goto, Takehiro Akahane, Hiroyuki Kimura, Akeri Mitsuda, Chiharu Kawanami, Yasushi Uchida, Chikara Ogawa, Atsunori Kusakabe, Ryuichi Narita, Yasushi Ide, Takehiko Abe, Keiji Tsuji, Tadashi Kitamura, Kazuhiko Okada, Tetsuro Sohda, Masaya Shigeno, Takashi Satou, Namiki Izumi
I whakaputaina 2018Artigo -
5
The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study mā Kaoru Tsuchiya, Masayuki Kurosaki, Azusa Sakamoto, Hiroyuki Marusawa, Yuji Kojima, Chitomi Hasebe, Hirotaka Arai, Kouji Joko, Masahiko Kondo, Keiji Tsuji, Tetsuro Sohda, Hiroyuki Kimura, Chikara Ogawa, Yasushi Uchida, Shuichi Wada, Haruhiko Kobashi, Koichiro Furuta, Masaya Shigeno, Atsunori Kusakabe, Takehiro Akahane, Ryoichi Narita, Hideo Yoshida, Akeri Mitsuda, Yasushi Ide, Tomomichi Matsushita, Namiki Izumi
I whakaputaina 2021Artigo -
6
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection mā Man‐Fung Yuen, Seng Gee Lim, Robert Pleśniak, Keiji Tsuji, Harry L.A. Janssen, Cristina Pojoga, Adrián Gadano, Corneliu Petru Popescu, Tatyana Stepanova, Tarik Asselah, Gheorghe Diaconescu, Hyung Joon Yim, Jeong Heo, Ewa Janczewska, Alexander Wong, Nevin Idriz, Michio Imamura, Giuliano Rizzardini, Koichi Takaguchi, Pietro Andreoné, Manuela Arbune, Jinlin Hou, Sung Jae Park, A Vâţă, Jennifer Cremer, Robert C. Elston, Tamara Lukić, Geoff Quinn, Lauren Maynard, Stuart Kendrick, Helene Plein, Fiona Campbell, Melanie Paff, Dickens Theodore
I whakaputaina 2022Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Gastroenterology
Internal medicine
Confidence interval
Hepatocellular carcinoma
Virus
Biology
Hazard ratio
Immunology
Oncology
Randomized controlled trial
Virology
Adverse effect
Alternative medicine
Antithrombin
Antiviral therapy
Atezolizumab
Bevacizumab
Cancer
Chemistry
Chemotherapy
Chronic hepatitis
Coinfection
Combination therapy
Gene
Genetics
Hepacivirus
Heparin
Hepatitis B
Hepatitis B virus